23andMe admits FDA order 'significantly slowed up' new customers

The Guardian (London)

Genetics will be a cheap and critical part of daily life, 23andMe co-founder Anne Wojcicki has told the SXSW festival, claiming that genetics should be used for preventive medicine to bring down the cost of healthcare.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
Humana, UnitedHealthcare, Aetna fall in new MA star ratings
2
2024 Best Places to Work in Healthcare winners announced
3
Why health systems are teaming up to create companies
4
Home health providers, CMS raise red flags over delayed access
5
Microsoft, Epic partner on AI tool to reduce nursing burnout